Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELASE Study: Lascufloxacin for Adult Group A Streptococcal Pharyngotonsillitis
jRCTs051240134Active, not recruiting
- Sponsor
- Kyorin Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lascufloxacin in tonsillopharyngitis, sponsored by Kyorin Pharmaceutical. Primary endpoint: Clinical efficacy rate at end of treatment (EOT). Started Nov 2024; status: active, not recruiting.
02
Drugs
lascufloxacin
03
Conditions
tonsillopharyngitis
Beyond the preview
Go deeper on jRCTs051240134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240134.